The DOI matches its Crossref record; 164 of the 164 references it cites were found in a registry or an index.
Oxidative Stress and Beta Amyloid in Alzheimer’s Disease. Which Comes First: The Chicken or the Egg?
Open accessAbstract
The pathogenesis of Alzheimer’s disease involves β amyloid (Aβ) accumulation known to induce synaptic dysfunction and neurodegeneration. The brain’s vulnerability to oxidative stress (OS) is considered a crucial detrimental factor in Alzheimer’s disease. OS and Aβ are linked to each other because Aβ induces OS, and OS increases the Aβ deposition. Thus, the answer to the question “which comes first: the chicken or the egg?” remains extremely difficult. In any case, the evidence for the primary occurrence of oxidative stress in AD is attractive. Thus, evidence indicates that a long period of gradual oxidative damage accumulation precedes and results in the appearance of clinical and pathological AD symptoms, including Aβ deposition, neurofibrillary tangle formation, metabolic dysfunction, and cognitive decline. Moreover, oxidative stress plays a crucial role in the pathogenesis of many risk factors for AD. Alzheimer’s disease begins many years before its symptoms, and antioxidant treatment can be an important therapeutic target for attacking the disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Scheltens, P., De Strooper, B., Kivipelto, M., Holstege, H., Chételat, G., Teunissen, C. E., Cummings, J., & van der Flier, W. M. (2021) · The Lancet · doi:10.1016/s0140-6736(20)32205-4 · Cited by 5,465
Vassar, R., Bennett, B. D., Babu-Khan, S., Kahn, S., Mendiaz, E. A., Denis, P., Teplow, D. B., Ross, S., Amarante, P., Loeloff, R., et al. (1999) · Science · doi:10.1126/science.286.5440.735 · Cited by 3,876 · cited 2×
“C99 is further cleaved, within the membrane, by the γ-secretase [25].”
BackgroundAlzheimer Disease: An Update on Pathobiology and Treatment Strategies
Long, J. M., & Holtzman, D. M. (2019) · Cell · doi:10.1016/j.cell.2019.09.001 · Cited by 3,204
Neuroinflammation and microglial activation in Alzheimer disease: where do we go from here?
Leng, F., & Edison, P. (2021) · Nature Reviews Neurology · doi:10.1038/s41582-020-00435-y · Cited by 3,179
Pellerin, L., & Magistretti, P. J. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.22.10625 · Cited by 2,927 · cited 1×
“This phenomenon, termed the astrocyte-to-neuron lactate shuttle (ANLS), was first described by Pellerin and Magistretti in the 1990s [155] and is supported by accumulating evidence [156,157].”
BackgroundLane, C. A., Hardy, J., & Schott, J. M. (2018) · European Journal of Neurology · doi:10.1111/ene.13439 · Cited by 2,616
Cell Biology of Ischemia/Reperfusion Injury
(2012) · International Review of Cell and Molecular Biology · doi:10.1016/b978-0-12-394309-5.00006-7 · Cited by 2,178
Copper, iron and zinc in Alzheimer's disease senile plaques
Lovell, M. A., Robertson, J. D., Teesdale, W. J., Campbell, J. L., & Markesbery, W. R. (1998) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(98)00092-6 · Cited by 2,120
Oxidative stress, dysfunctional glucose metabolism and Alzheimer disease
Butterfield, D. A., & Halliwell, B. (2019) · Nature Reviews Neuroscience · doi:10.1038/s41583-019-0132-6 · Cited by 1,954 · cited 1×
“Although the brain was once considered an insulin-independent organ, insulin signalling is now recognised as being central to neuronal health and to the function of synapses and brain circuits [145].”
BackgroundAβ peptide vaccination prevents memory loss in an animal model of Alzheimer's disease
Morgan, D., Diamond, D. M., Gottschall, P. E., Ugen, K. E., Dickey, C., Hardy, J., Duff, K., Jantzen, P., DiCarlo, G., Wilcock, D., et al. (2000) · Nature · doi:10.1038/35050116 · Cited by 1,498
Lactate in the brain: from metabolic end-product to signalling molecule
Magistretti, P. J., & Allaman, I. (2018) · Nature Reviews Neuroscience · doi:10.1038/nrn.2018.19 · Cited by 1,298
Huang, X., Atwood, C. S., Hartshorn, M. A., Multhaup, G., Goldstein, L. E., Scarpa, R. C., Cuajungco, M. P., Gray, D. N., Lim, J., Moir, R. D., et al. (1999) · Biochemistry · doi:10.1021/bi990438f · Cited by 1,107
Trafficking and Proteolytic Processing of APP
Haass, C., Kaether, C., Thinakaran, G., & Sisodia, S. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006270 · Cited by 1,075
Cutler, R. G., Kelly, J., Storie, K., Pedersen, W. A., Tammara, A., Hatanpaa, K., Troncoso, J. C., & Mattson, M. P. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0305799101 · Cited by 1,008
Molecular and cellular mechanisms underlying the pathogenesis of Alzheimer’s disease
Guo, T., Zhang, D., Zeng, Y., Huang, T. Y., Xu, H., & Zhao, Y. (2020) · Molecular Neurodegeneration · doi:10.1186/s13024-020-00391-7 · Cited by 994
Bomfim, T. R., Forny-Germano, L., Sathler, L. B., Brito-Moreira, J., Houzel, J.-C., Decker, H., Silverman, M. A., Kazi, H., Melo, H. M., McClean, P. L., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci57256 · Cited by 832
Atomic-resolution structure of a disease-relevant Aβ(1–42) amyloid fibril
Wälti, M. A., Ravotti, F., Arai, H., Glabe, C. G., Wall, J. S., Böckmann, A., Güntert, P., Meier, B. H., & Riek, R. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1600749113 · Cited by 808
The Alzheimer’s disease mitochondrial cascade hypothesis: progress and perspectives
Swerdlow, R. H., Burns, J. M., & Khan, S. M. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.09.010 · Cited by 786
Hypoxia facilitates Alzheimer's disease pathogenesis by up-regulating BACE1 gene expression
Sun, X., He, G., Qing, H., Zhou, W., Dobie, F., Cai, F., Staufenbiel, M., Huang, L. E., & Song, W. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0606298103 · Cited by 605 · cited 10×
“These events are followed by both Aβ overproduction and apoptosis [114] Furthermore, it has been shown that oxidative stress increases the activity of gamma secretase both in vitro and in vivo, and the increased expression of BACE1 induced by OS is regulated by gamma secretase [115,116].”
BackgroundInfluentialReactive oxygen species enhance insulin sensitivity
Loh, K., Deng, H., Fukushima, A., Cai, X., Boivin, B., Galic, S., Bruce, C., Shields, B. J., Skiba, B., Ooms, L. M., et al. (2009) · Cell Metabolism · doi:10.1016/j.cmet.2009.08.009 · Cited by 581
β-Secretase Protein and Activity Are Increased in the Neocortex in Alzheimer Disease
Fukumoto, H. (2002) · Archives of Neurology · doi:10.1001/archneur.59.9.1381 · Cited by 575
Receptor for AGE (RAGE): Signaling mechanisms in the pathogenesis of diabetes and its complications
Ramasamy, R., Yan, S. F., & Schmidt, A. M. (2011) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2011.06320.x · Cited by 521
Cribbs, D. H., Berchtold, N. C., Perreau, V., Coleman, P. D., Rogers, J., Tenner, A. J., & Cotman, C. W. (2012) · Journal of Neuroinflammation · doi:10.1186/1742-2094-9-179 · Cited by 499
Blázquez, E., Velázquez, E., Hurtado-Carneiro, V., & Ruiz-Albusac, J. M. (2014) · Frontiers in Endocrinology · doi:10.3389/fendo.2014.00161 · Cited by 491
Amyloid β protein immunotherapy neutralizes Aβ oligomers that disrupt synaptic plasticity in vivo
Klyubin, I., Walsh, D. M., Lemere, C. A., Cullen, W. K., Shankar, G. M., Betts, V., Spooner, E. T., Jiang, L., Anwyl, R., Selkoe, D. J., et al. (2005) · Nature Medicine · doi:10.1038/nm1234 · Cited by 489
The NLRP3 and NLRP1 inflammasomes are activated in Alzheimer’s disease
Saresella, M., La Rosa, F., Piancone, F., Zoppis, M., Marventano, I., Calabrese, E., Rainone, V., Nemni, R., Mancuso, R., & Clerici, M. (2016) · Molecular Neurodegeneration · doi:10.1186/s13024-016-0088-1 · Cited by 489
Drug development in Alzheimer’s disease: the path to 2025
Cummings, J., Aisen, P. S., DuBois, B., Frölich, L., Jack, C. R., Jones, R. W., Morris, J. C., Raskin, J., Dowsett, S. A., & Scheltens, P. (2016) · Alzheimer's Research & Therapy · doi:10.1186/s13195-016-0207-9 · Cited by 459
Brosseron, F., Krauthausen, M., Kummer, M., & Heneka, M. T. (2014) · Molecular Neurobiology · doi:10.1007/s12035-014-8657-1 · Cited by 447
Spatial correlation between brain aerobic glycolysis and amyloid-β (Aβ) deposition
Vlassenko, A. G., Vaishnavi, S. N., Couture, L., Sacco, D., Shannon, B. J., Mach, R. H., Morris, J. C., Raichle, M. E., & Mintun, M. A. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1010461107 · Cited by 404
Oxidative stress increases expression and activity of BACE in NT2 neurons
Tamagno, E., Bardini, P., Obbili, A., Vitali, A., Borghi, R., Zaccheo, D., Pronzato, M. A., Danni, O., Smith, M. A., Perry, G., et al. (2002) · Neurobiology of Disease · doi:10.1006/nbdi.2002.0515 · Cited by 385
Self-citationPurified and synthetic Alzheimer’s amyloid beta (Aβ) prions
Stöhr, J., Watts, J. C., Mensinger, Z. L., Oehler, A., Grillo, S. K., DeArmond, S. J., Prusiner, S. B., & Giles, K. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1206555109 · Cited by 361
Mendez, M. F. (2017) · Neurologic Clinics · doi:10.1016/j.ncl.2017.01.005 · Cited by 356
Suh, S. W., Jensen, K. B., Jensen, M. S., Silva, D. S., Kesslak, P. J., Danscher, G., & Frederickson, C. J. (2000) · Brain Research · doi:10.1016/s0006-8993(99)02096-x · Cited by 350
Tamagno, E., Guglielmotto, M., Aragno, M., Borghi, R., Autelli, R., Giliberto, L., Muraca, G., Danni, O., Zhu, X., Smith, M. A., et al. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.05072.x · Cited by 338
Self-citationTamagno, E., Parola, M., Bardini, P., Piccini, A., Borghi, R., Guglielmotto, M., Santoro, G., Davit, A., Danni, O., Smith, M. A., et al. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02895.x · Cited by 324
Self-citationHypoxia and brain aging: Neurodegeneration or neuroprotection?
Burtscher, J., Mallet, R. T., Burtscher, M., & Millet, G. P. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101343 · Cited by 324
Alzheimer disease, the two-hit hypothesis: An update
Zhu, X., Lee, H.-G., Perry, G., & Smith, M. A. (2007) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2006.10.014 · Cited by 292
Metabolic adaptation in hypoxia and cancer
Paredes, F., Williams, H. C., & San Martin, A. (2021) · Cancer Letters · doi:10.1016/j.canlet.2020.12.020 · Cited by 259
Guglielmotto, M., Aragno, M., Autelli, R., Giliberto, L., Novo, E., Colombatto, S., Danni, O., Parola, M., Smith, M. A., Perry, G., et al. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05858.x · Cited by 243
Self-citationRostami, J., Mothes, T., Kolahdouzan, M., Eriksson, O., Moslem, M., Bergström, J., Ingelsson, M., O’Callaghan, P., Healy, L. M., Falk, A., et al. (2021) · Journal of Neuroinflammation · doi:10.1186/s12974-021-02158-3 · Cited by 239
The Role of Microglia and the Nlrp3 Inflammasome in Alzheimer's Disease
Hanslik, K. L., & Ulland, T. K. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.570711 · Cited by 236
AGE/RAGE in diabetic kidney disease and ageing kidney
Wu, X.-Q., Zhang, D.-D., Wang, Y.-N., Tan, Y.-Q., Yu, X.-Y., & Zhao, Y.-Y. (2021) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2021.05.025 · Cited by 228
Amyloid precursor protein processing and bioenergetics
Wilkins, H. M., & Swerdlow, R. H. (2017) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2016.08.009 · Cited by 223
Bhatia, V., & Sharma, S. (2021) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2020.117253 · Cited by 222
Hypoxia increases Aβ generation by altering β- and γ-cleavage of APP
Li, L., Zhang, X., Yang, D., Luo, G., Chen, S., & Le, W. (2009) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.10.011 · Cited by 221
Oxidative stress potentiates BACE1 gene expression and A? generation
Tong, Y., Zhou, W., Fung, V., Christensen, M. A., Qing, H., Sun, X., & Song, W. (2005) · Journal of Neural Transmission · doi:10.1007/s00702-004-0255-3 · Cited by 218
Xia, Y., Prokop, S., & Giasson, B. I. (2021) · Molecular Neurodegeneration · doi:10.1186/s13024-021-00460-5 · Cited by 218
Mitochondrial Dysfunction: Different Routes to Alzheimer’s Disease Therapy
Picone, P., Nuzzo, D., Caruana, L., Scafidi, V., & Di Carlo, M. (2014) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2014/780179 · Cited by 210
Role of reactive oxygen species in the progression of Alzheimer’s disease
Bhatt, S., Puli, L., & Patil, C. R. (2021) · Drug Discovery Today · doi:10.1016/j.drudis.2020.12.004 · Cited by 207
Tamagno, E., Robino, G., Obbili, A., Bardini, P., Aragno, M., Parola, M., & Danni, O. (2003) · Experimental Neurology · doi:10.1016/s0014-4886(02)00059-6 · Cited by 201
Self-citationHooda, J., Shah, A., & Zhang, L. (2014) · Nutrients · doi:10.3390/nu6031080 · Cited by 193
β-Amyloid Is Different in Normal Aging and in Alzheimer Disease
Piccini, A., Russo, C., Gliozzi, A., Relini, A., Vitali, A., Borghi, R., Giliberto, L., Armirotti, A., D'Arrigo, C., Bachi, A., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m501694200 · Cited by 193
Self-citationNeurovascular Dysfunction in Vascular Dementia, Alzheimer's and Atherosclerosis
Shabir, O., Berwick, J., & Francis, S. E. (2018) · BMC Neuroscience · doi:10.1186/s12868-018-0465-5 · Cited by 191
Hypoxia Inducible Factor-1 as a Target for Neurodegenerative Diseases
Zhang, Z., Yan, J., Chang, Y., ShiDu Yan, S., & Shi, H. (2011) · Current Medicinal Chemistry · doi:10.2174/092986711797200426 · Cited by 189
A mouse model for Glut-1 haploinsufficiency
Wang, D., Pascual, J. M., Yang, H., Engelstad, K., Mao, X., Cheng, J., Yoo, J., Noebels, J. L., & De Vivo, D. C. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl032 · Cited by 185
Yao, J., Du, H., Yan, S., Fang, F., Wang, C., Lue, L.-F., Guo, L., Chen, D., Stern, D. M., Gunn Moore, F. J., et al. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.4717-10.2011 · Cited by 184
Association between Stroke and Alzheimer's Disease: Systematic Review and Meta-Analysis
Zhou, J., Yu, J.-T., Wang, H.-F., Meng, X.-F., Tan, C.-C., Wang, J., Wang, C., & Tan, L. (2014) · Journal of Alzheimer's Disease · doi:10.3233/jad-140666 · Cited by 184
Nuclear factor‐kappa β as a therapeutic target for Alzheimer's disease
Jha, N. K., Jha, S. K., Kar, R., Nand, P., Swati, K., & Goswami, V. K. (2019) · Journal of Neurochemistry · doi:10.1111/jnc.14687 · Cited by 178
Epigenetics of Alzheimer’s Disease
Nikolac Perkovic, M., Videtic Paska, A., Konjevod, M., Kouter, K., Svob Strac, D., Nedic Erjavec, G., & Pivac, N. (2021) · Biomolecules · doi:10.3390/biom11020195 · Cited by 176
Amyloid β-protein and beyond: the path forward in Alzheimer’s disease
Walsh, D. M., & Selkoe, D. J. (2020) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2020.02.003 · Cited by 174
Iron uptake and transport across physiological barriers
Duck, K. A., & Connor, J. R. (2016) · BioMetals · doi:10.1007/s10534-016-9952-2 · Cited by 173
Oxidative stress and lipid peroxidation are upstream of amyloid pathology
Arimon, M., Takeda, S., Post, K. E., Svirsky, S. E., Hyman, B. T., & Berezovska, O. (2015) · Neurobiology of Disease · doi:10.1016/j.nbd.2015.06.013 · Cited by 169
Ganguly, U., Kaur, U., Chakrabarti, S. S., Sharma, P., Agrawal, B. K., Saso, L., & Chakrabarti, S. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/7086512 · Cited by 169
Heme Deficiency Selectively Interrupts Assembly of Mitochondrial Complex IV in Human Fibroblasts
Atamna, H., Liu, J., & Ames, B. N. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m108362200 · Cited by 164
β-Amyloid Mediated Nitration of Manganese Superoxide Dismutase
Muthuswamy, A., Tangpong, J., Keller, J. N., Murphy, M. P., Markesbery, W. R., Kiningham, K. K., & Clair, D. K. S. (2006) · American Journal Of Pathology · doi:10.2353/ajpath.2006.051223 · Cited by 155
Differential effects of glycation on protein aggregation and amyloid formation
Iannuzzi, C., Irace, G., & Sirangelo, I. (2014) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2014.00009 · Cited by 152
An anemia of Alzheimer's disease
Faux, N. G., Rembach, A., Wiley, J. S., Ellis, K. A., Ames, D. J., Fowler, C. J., Martins, R. N., Pertile, K. K., Rumble, R. L., Trounson, B. O., et al. (2014) · Molecular Psychiatry · doi:10.1038/mp.2013.178 · Cited by 151
Chang, Y., Chang, W., Tsai, N., Huang, C., Kung, C., Su, Y., Lin, W.-C., Cheng, B., Su, C.-M., Chiang, Y.-F., et al. (2014) · BioMed Research International · doi:10.1155/2014/182303 · Cited by 147
Lee, M., Yu, W., Shih, Y., Chen, C., Guo, Z., Huang, S., Chan, J. C. C., & Chen, Y. (2018) · Scientific Reports · doi:10.1038/s41598-018-23122-x · Cited by 143
Fleming, T. H., Humpert, P. M., Nawroth, P. P., & Bierhaus, A. (2010) · Gerontology · doi:10.1159/000322087 · Cited by 141
Zuo, L., Hemmelgarn, B. T., Chuang, C., & Best, T. M. (2015) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2015/604658 · Cited by 140
Unraveling the complex metabolic nature of astrocytes
Bouzier-Sore, A.-K., & Pellerin, L. (2013) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2013.00179 · Cited by 134
Hooijmans, C. R., Graven, C., Dederen, P. J. W. C., Tanila, H., van Groen, T., & Kiliaan, A. J. (2007) · Brain Research · doi:10.1016/j.brainres.2007.08.063 · Cited by 130
Mechanisms of NLRP3 Inflammasome Activation: Its Role in the Treatment of Alzheimer’s Disease
Zhang, Y., Zhao, Y., Zhang, J., & Yang, G. (2020) · Neurochemical Research · doi:10.1007/s11064-020-03121-z · Cited by 130
Association between chronic stress and Alzheimer’s disease: Therapeutic effects of Saffron
Saeedi, M., & Rashidy‐Pour, A. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110995 · Cited by 130
Takahashi, S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22126568 · Cited by 125
Extracellular signal‐regulated kinase regulates microglial immune responses in Alzheimer’s disease
Chen, M. J., Ramesha, S., Weinstock, L. D., Gao, T., Ping, L., Xiao, H., Dammer, E. B., Duong, D. D., Levey, A. I., Lah, J. J., et al. (2021) · Journal of Neuroscience Research · doi:10.1002/jnr.24829 · Cited by 122
Butterfield, D. A., Gnjec, A., Poon, H. F., Castegna, A., Pierce, W. M. J., Klein, J. B., & Martins, R. N. (2006) · Journal of Alzheimer s Disease · doi:10.3233/jad-2006-10407 · Cited by 121
Oxidative damage in Alzheimer's disease: the metabolic dimension
Perry, G. L., Nunomura, A., Hirai, K., Takeda, A., Aliev, G., & Smith, M. A. (2000) · International Journal of Developmental Neuroscience · doi:10.1016/s0736-5748(00)00006-x · Cited by 120
Jo, D., Arumugam, T. V., Woo, H., Park, J. S., Tang, S., Mughal, M. R., Hyun, D., Park, J.-H., Choi, Y., Gwon, A., et al. (2008) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2008.07.003 · Cited by 111
Duong, M. T., Nasrallah, I. M., Wolk, D. A., Chang, C. C. Y., & Chang, T. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.647990 · Cited by 111
Alzheimer’s disease and type 2 diabetes mellitus: A systematic review of proteomic studies
Pereira, J. D., Fraga, V. G., Santos, A. L. M., Ferriani, M. D. G. C., Caramelli, P., & Gomes, K. B. (2020) · Journal of Neurochemistry · doi:10.1111/jnc.15166 · Cited by 110
Regulation of β‐site APP‐cleaving enzyme 1 gene expression and its role in Alzheimer’s Disease
Sun, X., Bromley‐Brits, K., & Song, W. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07515.x · Cited by 105
Sheng, B., Gong, K., Niu, Y., Liu, L., Yan, Y., Lu, G., Zhang, L., Hu, M., Zhao, N., Zhang, X., et al. (2009) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2009.02.018 · Cited by 102
Xiang, Z., Haroutunian, V., Ho, L., Purohit, D., & Pasinetti, G. M. (2006) · Disease Markers · doi:10.1155/2006/276239 · Cited by 101
AGE–RAGE stress: a changing landscape in pathology and treatment of Alzheimer’s disease
Prasad, K. (2019) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-019-03553-4 · Cited by 101
Patil, S. P., Sheng, L., Masserang, A., & Chan, C. (2006) · Neuroscience Letters · doi:10.1016/j.neulet.2006.07.015 · Cited by 100
Comorbidity and progression of late onset Alzheimer’s disease: A systematic review
Haaksma, M. L., Vilela, L. R., Marengoni, A., Calderón‐Larrañaga, A., Leoutsakos, J., Rikkert, M. G. M. O., & Melis, R. J. F. (2017) · PLoS ONE · doi:10.1371/journal.pone.0177044 · Cited by 99
Friend, Foe or Both? Immune Activity in Alzheimer’s Disease
Frost, G. R., Jonas, L. A., & Li, Y. (2019) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2019.00337 · Cited by 98
Current Status of Clinical Trials on Tau Immunotherapies
Ji, C., & Sigurdsson, E. M. (2021) · Drugs · doi:10.1007/s40265-021-01546-6 · Cited by 96
Insulin signalling in Alzheimer′s disease and diabetes: from epidemiology to molecular links
Ribé, E. M., & Lovestone, S. (2016) · Journal of Internal Medicine · doi:10.1111/joim.12534 · Cited by 93
Zhang, J., Zhou, S., Wang, Q., Guo, J., Liang, H., Deng, J.-B., & He, W. (2016) · Neuroscience · doi:10.1016/j.neuroscience.2016.03.024 · Cited by 92
Alzheimer’s Disease: A Heme–Aβ Perspective
Ghosh, C., Seal, M., Mukherjee, S., & Dey, S. G. (2015) · Accounts of Chemical Research · doi:10.1021/acs.accounts.5b00102 · Cited by 92
Role of ABCA7 in Human Health and in Alzheimer’s Disease
Dib, S., Pahnke, J., & Gosselet, F. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094603 · Cited by 90
Critical Appraisal of Amyloid Lowering Agents in AD
Decourt, B., Boumelhem, F., Pope, E. D., Shi, J., Mari, Z. K., & Sabbagh, M. N. (2021) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-021-01125-y · Cited by 90
Hypoxia and Alzheimer’s disease
Peers, C., Pearson, H. A., & Boyle, J. P. (2007) · Essays in Biochemistry · doi:10.1042/bse0430153 · Cited by 87
Molecular subtypes of Alzheimer’s disease
Fede, G. D., Catania, M., Maderna, E., Ghidoni, R., Benussi, L., Tonoli, E., Giaccone, G., Moda, F., Paterlini, A., Campagnani, I., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-21641-1 · Cited by 87
Guzy, R. D., Mack, M. M., & Schumacker, P. T. (2007) · Antioxidants and Redox Signaling · doi:10.1089/ars.2007.1708 · Cited by 86
The increased activity of BACE1 correlates with oxidative stress in Alzheimer's disease
Borghi, R., Patriarca, S., Traverso, N., Piccini, A., Storace, D., Garuti, A., Cirmena, G., Odetti, P. R., & Tabaton, M. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2006.05.004 · Cited by 86
Self-citationEarly Life Stress and Epigenetics in Late-onset Alzheimer’s Dementia: A Systematic Review
Lemche, E. (2018) · Current Genomics · doi:10.2174/1389202919666171229145156 · Cited by 85
Karisetty, B. C., Bhatnagar, A., Armour, E. M., Beaver, M., Zhang, H., & Elefant, F. (2020) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2020.577622 · Cited by 83
Heme binding to Amyloid-β peptide: Mechanistic role in Alzheimer's disease
Atamna, H. (2006) · Journal of Alzheimer s Disease · doi:10.3233/jad-2006-102-310 · Cited by 79
The CD33 short isoform is a gain-of-function variant that enhances Aβ1–42 phagocytosis in microglia
Bhattacherjee, A., Jung, J., Zia, S., Ho, M. F. S., Eskandari‐Sedighi, G., Laurent, C. D. S., McCord, K. A., Bains, A., Sidhu, G., Sarkar, S., et al. (2021) · Molecular Neurodegeneration · doi:10.1186/s13024-021-00443-6 · Cited by 79
Ji, Y., Han, J., Lee, N., Yoon, J.-H., Youn, K., Ha, H. J., Yoon, E., Kim, D. H., & Jun, M. (2020) · Molecules · doi:10.3390/molecules25215087 · Cited by 78
Journey on Naphthoquinone and Anthraquinone Derivatives: New Insights in Alzheimer’s Disease
Campora, M., Francesconi, V., Schenone, S., Tasso, B., & Tonelli, M. (2021) · Pharmaceuticals · doi:10.3390/ph14010033 · Cited by 76
Paul, R. K., & Borah, A. (2017) · Scientific Reports · doi:10.1038/s41598-017-17911-z · Cited by 75
The interaction of zinc and the blood-brain barrier under physiological and ischemic conditions
Qi, Z., & Liu, K. J. (2018) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2018.12.018 · Cited by 72
Gamba, P., Guglielmotto, M., Testa, G., Monteleone, D., Zerbinati, C., Gargiulo, S., Biasi, F., Iuliano, L., Giaccone, G., Mauro, A., et al. (2014) · Aging Cell · doi:10.1111/acel.12206 · Cited by 69
Self-citationAltered expression and distribution of zinc transporters in APP/PS1 transgenic mouse brain
Zhang, L., Wang, X., Zheng, Z., Ren, H., Stoltenberg, M., Danscher, G., Huang, L., Rong, M., & Wang, Z. (2008) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2008.02.018 · Cited by 69
Li, S., Jin, M., Liu, L., Dang, Y., Ostaszewski, B. L., & Selkoe, D. J. (2018) · Acta Neuropathologica Communications · doi:10.1186/s40478-018-0626-x · Cited by 67
Rebelos, E., Rinne, J. O., Nuutila, P., & Ekblad, L. L. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10071532 · Cited by 66
Closing in on the Amyloid Cascade
Doms, R. W., & Huse, J. T. (2000) · Molecular Neurobiology · doi:10.1385/mn:22:1-3:081 · Cited by 66
Coffee and Maillard products activate NF‐κB in macrophages via H2O2 production
Muscat, S., Pelka, J., Hegele, J., Weigle, B., Münch, G. W., & Pischetsrieder, M. (2007) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.200600254 · Cited by 66
Kimura, A., Tsuji, M., Yasumoto, T., Mori, Y., Oguchi, T., Tsuji, Y., Umino, M., Umino, A., Nishikawa, T., Nakamura, S., et al. (2021) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2021.05.019 · Cited by 65
Pang, R., Wang, X., Pei, F., Zhang, W., Shen, J., Gao, X., & Chang, C. K. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-190328 · Cited by 64
Chiu, Y., Lin, C., Lee, M.-C., Hsieh‐Li, H. M., Chen, C., Wu, Y., Chang, K., & Lee‐Chen, G. (2021) · Aging · doi:10.18632/aging.203125 · Cited by 63
Amyloid-β: A double agent in Alzheimer's disease?
Yu, H., & Wu, J. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111575 · Cited by 62
The Role of Mitochondrial Dysfunction in the Progression of Alzheimer’s Disease
Desler, C., Lillenes, M. S., Tønjum, T., & Rasmussen, L. J. (2017) · Current Medicinal Chemistry · doi:10.2174/0929867324666170616110111 · Cited by 62
Mutant Presenilin 1 Increases the Expression and Activity of BACE1
Giliberto, L., Borghi, R., Piccini, A., Mangerini, R., Sorbi, S., Cirmena, G., Garuti, A., Ghetti, B. F., Tagliavini, F., Mughal, M. R., et al. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m805685200 · Cited by 61
Self-citationWei, Z., Meng, X., Fatimy, R. E., Sun, B., Mai, D., Zhang, J., Arora, R., Zeng, A., Xu, P., Qu, S., et al. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2019.104617 · Cited by 59
Franzmeier, N., Ossenkoppele, R., Brendel, M., Rubinski, A., Smith, R. A., Kumar, A., Mattsson, N., Strandberg, O. T., Duering, M., Büerger, K., et al. (2021) · Alzheimer s & Dementia · doi:10.1002/alz.12371 · Cited by 57
Systemic Oxidative Stress: A Key Point in Neurodegeneration — A Review
Leo, E. E. M., & Campos, M. R. S. (2019) · The journal of nutrition health & aging · doi:10.1007/s12603-019-1240-8 · Cited by 56
Rodríguez, M. H., Arciniega-Martínez, I. M., García-Marín, I. D., Correa‐Basurto, J., & Rosales‐Hernández, M. C. (2020) · Molecular Neurobiology · doi:10.1007/s12035-020-02009-x · Cited by 54
An old medicine as a new drug to prevent mitochondrial complex I from producing oxygen radicals
Détaille, D., Pasdois, P., Sémont, A., Santos, P. D. D., & Diolez, P. (2019) · PLoS ONE · doi:10.1371/journal.pone.0216385 · Cited by 53
Banerjee, P., Sahoo, A., Anand, S., Ganguly, A., Righi, G., Bovicelli, P., Saso, L., & Chakrabarti, S. (2014) · NeuroMolecular Medicine · doi:10.1007/s12017-014-8328-4 · Cited by 52
The Pathophysiology of Heme in the Brain
Gozzelino, R. (2015) · Current Alzheimer Research · doi:10.2174/1567205012666150921103304 · Cited by 52
Tofighi, N., Asle‐Rousta, M., Rahnema, M., & Amini, R. (2021) · NeuroToxicology · doi:10.1016/j.neuro.2021.06.002 · Cited by 50
Tamagno, E., Guglielmotto, M., Bardini, P., Santoro, G., Davit, A., Simone, D. D., Danni, O., & Tabaton, M. (2003) · Neurobiology of Disease · doi:10.1016/s0969-9961(03)00131-1 · Cited by 47
Self-citationBehl, T., Kaur, I., Frățilă, O., Brata, R. D., & BUNGAU, S. G. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21207443 · Cited by 47
Testa, G., Staurenghi, E., Giannelli, S., Gargiulo, S., Guglielmotto, M., Tabaton, M., Tamagno, E., Gamba, P., & Leonarduzzi, G. (2018) · Redox Biology · doi:10.1016/j.redox.2018.05.009 · Cited by 46
Self-citationMeng, M., Zhang, L., Di, A. I., Wu, H., & Peng, W. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.659955 · Cited by 46
The human β-amyloid precursor protein: biomolecular and epigenetic aspects
Nguyen, K. V. (2015) · BioMolecular Concepts · doi:10.1515/bmc-2014-0041 · Cited by 45
Fagiani, F., Lanni, C., Racchi, M., & Govoni, S. M. (2021) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2021.635880 · Cited by 44
Xu, J., Guo, S., Xue, R., Xiao, L., Kou, J., Liu, Y., Han, J., Fu, J.-J., & Wei, N. (2021) · Aging · doi:10.18632/aging.203009 · Cited by 43
Heme and hemoglobin suppress amyloid β–mediated inflammatory activation of mouse astrocytes
Sankar, S. B., Donegan, R. K., Shah, K. J., Reddi, A. R., & Wood, L. B. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra117.001050 · Cited by 42
Sen, A., Nelson, T. J., Alkon, D. L., & Hongpaisan, J. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-171008 · Cited by 41
Novel therapeutic strategies for Alzheimer’s disease targeting brain cholesterol homeostasis
Samant, N. P., & Gupta, G. L. (2020) · European Journal of Neuroscience · doi:10.1111/ejn.14949 · Cited by 40
Yang, X., Zhi, J., Leng, H., Chen, Y., Gao, H., Ma, J., Ji, J., & Hu, Q. (2021) · Phytomedicine · doi:10.1016/j.phymed.2021.153571 · Cited by 40
Huang, X., Zhao, X., Li, B., Cai, Y., Zhang, S., Yu, F., & Wan, Q. (2021) · Experimental Gerontology · doi:10.1016/j.exger.2021.111424 · Cited by 39
Elevated soluble amyloid beta protofibrils in Down syndrome and Alzheimer's disease
Johannesson, M., Sahlin, C., Söderberg, L., Basun, H., Fälting, J. M., Möller, C., Zachrisson, O., Sunnemark, D., Svensson, A., Odergren, T., et al. (2021) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2021.103641 · Cited by 37
Koike, H., Iguchi, Y., Sahashi, K., & Katsuno, M. (2021) · Molecules · doi:10.3390/molecules26165091 · Cited by 36
Ullner, P. M., Nardo, A. D., Goldman, J. E., Schobel, S., Yang, H., Engelstad, K., Wang, D., Şahin, M., & Vivo, D. C. D. (2009) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.06.014 · Cited by 35
Mitsumori, R., Sakaguchi, K., Shigemizu, D., Mori, T., Akiyama, S., Ozaki, K., Niida, S., & Shimoda, N. (2020) · PLOS ONE · doi:10.1371/journal.pone.0239196 · Cited by 34
Amyloid-β Metabolite Sensing: Biochemical Linking of Glycation Modification and Misfolding
Fawver, J. N., Schall, H. E., Chapa, R. P., Zhu, X., & Murray, I. V. J. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-112114 · Cited by 32
Butterfield, D. A., & Castegna, A. (2003) · PubMed · Cited by 31
Syeda, T., & Cannon, J. R. (2021) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.22694 · Cited by 31
Ashour, N. H., El-Tanbouly, D. M., Sayed, N. S. E., & Khattab, M. M. (2021) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2021.110366 · Cited by 30
Villa, V., Thellung, S., Bajetto, A., Gatta, E., Robello, M., Novelli, F., Tasso, B., Tonelli, M., & Florio, T. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.09.010 · Cited by 29
Hu, Z., Fang, W., Liu, Y., Liang, H., Chen, W., & Wang, H. (2021) · Molecular Medicine Reports · doi:10.3892/mmr.2021.11969 · Cited by 29
McCarty, M. F., DiNicolantonio, J. J., & Lerner, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22042140 · Cited by 28
Zhou, X., Fu, A. K. Y., & Ip, N. Y. (2021) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2021.02.001 · Cited by 23
DNA damage-inducing agents elicit γ-secretase activation mediated by oxidative stress
Jin, S. M., Cho, H., Jung, E. S., Shim, M.-Y., & Mook‐Jung, I. (2008) · Cell Death and Differentiation · doi:10.1038/cdd.2008.49 · Cited by 21
An, N., Fu, Y., Shi, J., Guo, H., Yang, Z., Li, Y., Li, S., Wang, Y., Yao, Z., Hu, B., et al. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-201162 · Cited by 20
Xu, W., Initiative, A. D. N., Tan, C., Cao, X., & Tan, L. (2020) · Aging · doi:10.18632/aging.103814 · Cited by 16
Guglielmotto, M., Repetto, I. E., Monteleone, D., Vasciaveo, V., Franchino, C., Rinaldi, S., Tabaton, M., & Tamagno, E. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-190494 · Cited by 15
Self-citationSun, Z., Ma, C., Li, G., Zheng, X., Hao, Y., Yu, Y., & Wang, X. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.654611 · Cited by 14
Vanacore, R., Eskew, J. D., Sung, L. H., Davis, T., & Smith, A. (2019) · BioMetals · doi:10.1007/s10534-019-00194-4 · Cited by 13
Soluble amyloid-β in the brain: The scarlet pimpernel
Tabaton, M., & Gambetti, P. L. (2006) · Journal of Alzheimer s Disease · doi:10.3233/jad-2006-9s315 · Cited by 10
Self-citationLana, E., Gellerbring, A., Jung, S., Nordberg, A. K., Lithner, C. U., & Darreh‐Shori, T. (2019) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2019.00176 · Cited by 10
Youn, K., & Jun, M. (2020) · Journal of Medicinal Food · doi:10.1089/jmf.2019.4613 · Cited by 10
Bennett, J. P. (2019) · Medical Hypotheses · doi:10.1016/j.mehy.2019.03.034 · Cited by 9
Wang, K., Na, L., & Duan, M. (2020) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026620666200916123000 · Cited by 6
Masand, N., Gupta, S. P., & Khosa, R. L. (2018) · Current Drug Discovery Technologies · doi:10.2174/1570163814666170713103440 · Cited by 4
Ma, L., Liu, S., Du, J., Niu, Y., Hou, P.-F., Shu, Q., Ma, R., Wu, S., Qu, Q., & Lv, Y.-L. (2020) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2019.107155 · Cited by 3
Cited by
Dash, U. C., Bhol, N. K., Swain, S. K., Samal, R. R., Nayak, P. K., Raina, V., Panda, S. K., Kerry, R. G., Duttaroy, A. K., & Jena, A. B. (2025) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2024.10.004 · Cited by 700
Afzal, S., Abdul Manap, A. S., Attiq, A., Albokhadaim, I., Kandeel, M., & Alhojaily, S. M. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1269581 · Cited by 416
Jurcău, M. C., Andronie-Cioara, F. L., Jurcău, A., Marcu, F., Ţiț, D. M., Pașcalău, N., & Nistor-Cseppentö, D. C. (2022) · Antioxidants · doi:10.3390/antiox11112167 · Cited by 226
Alkhalifa, A. E., Alkhalifa, O., Durdanovic, I., Ibrahim, D. R., & Maragkou, S. (2025) · Journal of Dementia and Alzheimer's Disease · doi:10.3390/jdad2020017 · Cited by 66
Lyu, Y., Meng, Z., Hu, Y., Jiang, B., Yang, J., Chen, Y., Zhou, J., Li, M., & Wang, H. (2024) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2024.1394932 · Cited by 42
Metadata
- Authors
- Tamagno, E., Guglielmotto, M., Vasciaveo, V., & Tabaton, M.
- Venue
- Antioxidants
- Publisher
- MDPI AG
- Published
- 2021-09-16
- Volume
- 10
- Issue
- 9
- Pages
- 1479
- ISSN
- 2076-3921 (ISSN-L)
- OpenAlex
- W3199727148
- Cited by
- 264
- References
- 164
- FWCI
- 16.45
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.